ADDvise signs Letter of Intent to acquire MRC Systems Ltd - Regulatory information

26-10-2020   Regulatory press release

ADDvise Group AB (publ) (”ADDvise”) has signed a Letter of Intent with the shareholders of MRC Systems Ltd (the ”Company” and ”MRC”) regarding an acquisition of 100 percent of the shares in MRC (the ”Acquisition”).

MRC develops and manufactures cleanrooms for the pharmaceutical industry and hospitals. The Company has its headquarters and production facility located in Dubai. The Company owns an additional production facility in Spain. The Company’s revenue is expected to amount to approximately USD 9.80 million with an adjusted EBITDA of approximately USD 1.10 million for the financial year 2019/2020. The Company currently employs around 110 people.

The purchase price amounts to a total of approximately USD 8.00 million, divided into an initial payment of approximately USD 5.00 million and two potential earn-outs of maximum and approximately USD 1.50 million each, given that the sellers achieve certain predetermined targets. Included in the purchase price is a debt-free production facility of an estimated value of USD 1.30 million. The Acquisition is financed through own funds and loan. ADDvise assess that the Acquisition will have a positive impact on ADDvise earnings per share during the financial year 2021.

The Acquisition is subject to a due diligence and that the parties agree to enter into a share purchase agreement. The share purchase agreement and admission are scheduled to be completed during Q1 2021.

”MRC is a great and profitable business with a strong position in the cleanroom industry. The Company has been a partner to one of our subsidiaries for many years. The acquisition widens ADDvise’s geographical presence and broadens our product portfolio within the lab segment”, says Rikard Akhtarzand, CEO of ADDvise.

For further information, please contact:

Rikard Akhtarzand, VD
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 26 October 2020 at 08:55 CET.
 

Om ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected

Regulatory

The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million

Regulatory

ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…